We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Under a voluntary initiative set to take effect this month, Oklahoma will introduce value-based drug purchasing for Medicaid, only fully compensating manufacturers of drugs that deliver the promised results. Read More
CVS and Rite Aid filed an antitrust suit accusing AbbVie of mounting “sham” patent lawsuits against two generic manufacacturers to protect its testosterone replacement drug AndroGel from competition. Read More
In the first 100 days since the Trump administration issued its American Patients First blueprint, 15 drug companies have cut list prices, reversed planned price hikes or called for price freezes for the rest of the year, HHS says in a report released Tuesday. Read More
The FDA issued warning letters in May to three U.S. distributors of more than 65 kratom products for sales of unapproved new drugs claiming effectiveness in treating opioid addiction and withdrawal. Read More
Sponsors conducting nonclinical radiopharmaceutical diagnostic drug trials can seek waivers for specific nonclinical pharmacology or toxicology studies, according to final guidance from the FDA. Read More
The FDA released final guidance Monday on quality attributes sponsors should consider for chewable tablets, suggesting they should be easy to chew, have a “bearable” taste and disintegrate easily. Read More